Nora Wong

2.8k total citations
41 papers, 1.7k citations indexed

About

Nora Wong is a scholar working on Genetics, Cancer Research and Oncology. According to data from OpenAlex, Nora Wong has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Genetics, 19 papers in Cancer Research and 16 papers in Oncology. Recurrent topics in Nora Wong's work include BRCA gene mutations in cancer (25 papers), Cancer Genomics and Diagnostics (14 papers) and Genetic factors in colorectal cancer (9 papers). Nora Wong is often cited by papers focused on BRCA gene mutations in cancer (25 papers), Cancer Genomics and Diagnostics (14 papers) and Genetic factors in colorectal cancer (9 papers). Nora Wong collaborates with scholars based in Canada, United States and Norway. Nora Wong's co-authors include William D. Foulkes, Louis R. Bégin, Pierre O. Chappuis, Jean‐Sébastien Brunet, John R. Goffin, Nancy Hamel, Linda Kapusta, Ingunn M. Stefansson, Lars A. Akslen and Steven A. Narod and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Cancer.

In The Last Decade

Nora Wong

39 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nora Wong Canada	20	852	768	726	638	376	41	1.7k
Hermela Shimelis United States	15	957 1.1×	821 1.1×	625 0.9×	595 0.9×	375 1.0×	24	1.7k
Edenir Inêz Palmero Brazil	20	564 0.7×	751 1.0×	522 0.7×	610 1.0×	275 0.7×	78	1.4k
Rita K. Schmutzler Germany	21	1.2k 1.4×	523 0.7×	626 0.9×	438 0.7×	493 1.3×	77	1.9k
Joanne L. Blum United States	15	745 0.9×	518 0.7×	521 0.7×	1.0k 1.6×	149 0.4×	21	1.8k
Valérie‐Jeanne Bardou France	19	398 0.5×	611 0.8×	698 1.0×	895 1.4×	228 0.6×	25	1.8k
Brian Allen United States	17	996 1.2×	675 0.9×	946 1.3×	1.2k 1.8×	1.4k 3.8×	39	2.4k
Rebecca Roylance United Kingdom	28	471 0.6×	1.2k 1.6×	966 1.3×	1.1k 1.7×	856 2.3×	77	2.6k
Kasmintan A. Schrader Canada	19	597 0.7×	465 0.6×	341 0.5×	306 0.5×	398 1.1×	75	1.4k
Peggy Manders Netherlands	21	300 0.4×	579 0.8×	529 0.7×	622 1.0×	170 0.5×	43	1.3k
Eija Mahlamäki Finland	19	309 0.4×	781 1.0×	417 0.6×	641 1.0×	187 0.5×	35	1.7k

Countries citing papers authored by Nora Wong

Since Specialization

Citations

This map shows the geographic impact of Nora Wong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Wong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Wong more than expected).

Fields of papers citing papers by Nora Wong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Wong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Wong. The network helps show where Nora Wong may publish in the future.

Co-authorship network of co-authors of Nora Wong

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Wong. A scholar is included among the top collaborators of Nora Wong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Wong. Nora Wong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Basik, Mark, Jean Francois Boileau, Sarkis Meterissian, et al.. (2025). Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age. Annals of Surgical Oncology. 33(1). 108–117.

Wong, Stephanie M., Mark Basik, Sarkis Meterissian, et al.. (2025). Chemotherapy receipt in affected BRCA1/2 and PALB2 carriers with operable breast cancer: the impact of early detection and pre-diagnostic awareness on clinical outcomes and treatment. Hereditary Cancer in Clinical Practice. 23(1). 14–14. 1 indexed citations

Basik, Mark, Jean Francois Boileau, Sarkis Meterissian, et al.. (2024). Timing of genetic testing in BRCA1/2 and PALB2-Associated breast cancer: Preoperative result disclosure increases uptake of risk-reducing mastectomy and reduces unnecessary exposure to radiotherapy. European Journal of Surgical Oncology. 50(6). 108324–108324. 5 indexed citations

Basik, Mark, Jean Francois Boileau, Sarkis Meterissian, et al.. (2024). Pathologic complete response rates in BRCA1/2 and PALB2-associated breast cancer treated with neoadjuvant chemotherapy. European Journal of Surgical Oncology. 50. 108855–108855.

Papadakis, Andreas I., et al.. (2023). Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancer. Lung Cancer. 181. 107247–107247. 1 indexed citations

Viezel-Mathieu, Alex, Mark Basik, Jean Francois Boileau, et al.. (2023). Surgical Decision Making in Genetically High-Risk Women: Quantifying Postoperative Complications and Long-Term Risks of Supplemental Surgery After Risk-Reducing Mastectomy. Annals of Surgical Oncology. 31(1). 356–364. 1 indexed citations

Wong, Stephanie M., Mark Basik, Jean Francois Boileau, et al.. (2022). Incidence of Occult Breast Cancer in Carriers of BRCA1/2 or Other High-Penetrance Pathogenic Variants Undergoing Prophylactic Mastectomy: When is Sentinel Lymph Node Biopsy Indicated?. Annals of Surgical Oncology. 29(11). 6660–6668. 11 indexed citations

Foulkes, William D., Pavel Hamet, Jacques Simard, et al.. (2017). No Evidence of Excessive Cancer Screening in Female Noncarriers from BRCA1/2 Mutation–Positive Families. Current Oncology. 24(6). 352–359. 3 indexed citations

Loiselle, Carmen G., et al.. (2013). Experience of BRCA1/2 mutation-negative young women from families with hereditary breast and ovarian cancer: a qualitative study. Hereditary Cancer in Clinical Practice. 11(1). 14–14. 7 indexed citations

10.

Loiselle, Carmen G., et al.. (2010). Decision-Making Process of Women Carrying a <i>BRCA1</i> or <i>BRCA2</i> Mutation Who Have Chosen Prophylactic Mastectomy. Oncology nursing forum. 37(3). 313–320. 17 indexed citations

11.

Wong, Nora, George Chong, Gretchen Schneider, et al.. (2009). A comparison of models used to predict MLH1, MSH2 and MSH6 mutation carriers. Annals of Oncology. 20(4). 681–688. 24 indexed citations

12.

Li, Lili, Kajal Biswas, Sergey G. Kuznetsov, et al.. (2009). Functional redundancy of exon 12 ofBRCA2revealed by a comprehensive analysis of the c.6853A>G (p.I2285V) variant. Human Mutation. 30(11). 1543–1550. 26 indexed citations

13.

Hamel, Nancy, et al.. (2007). Mixed Ovarian Germ Cell Tumor in a BRCA2 Mutation Carrier. International Journal of Gynecological Pathology. 26(2). 160–164. 6 indexed citations

14.

Li, Lili, Isabelle Thiffault, Philip H. Gordon, et al.. (2006). The Value of Multi-Modal Gene Screening in HNPCC in Quebec: Three Mutations in Mismatch Repair Genes that would have not been Correctly Identified by Genomic DNA Sequencing Alone. Familial Cancer. 5(1). 21–28. 6 indexed citations

15.

Chappuis, Pierre O., John R. Goffin, Nora Wong, et al.. (2005). Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment. Annals of Oncology. 16(5). 735–742. 39 indexed citations

16.

Robson, Mark E., Pierre O. Chappuis, Jaya M. Satagopan, et al.. (2003). A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment. Breast Cancer Research. 6(1). R8–R17. 212 indexed citations

17.

Straume, Oddbjørn, et al.. (2003). Glomeruloid microvascular proliferation is associated with p53 expression, germline BRCA1 mutations and an adverse outcome following breast cancer. British Journal of Cancer. 89(6). 1031–1034. 42 indexed citations

18.

Goffin, John R., Pierre O. Chappuis, Louis R. Bégin, et al.. (2003). Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma. Cancer. 97(3). 527–536. 80 indexed citations

19.

Rabelo, Rogério, William D. Foulkes, Philip H. Gordon, et al.. (2001). Role of molecular diagnostic testing in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer families. Diseases of the Colon & Rectum. 44(3). 437–446. 20 indexed citations

20.

Davies, Corinne S., et al.. (1994). Isolation of Arabidopsis thaliana mutants hypersensitive to gamma radiation. Molecular and General Genetics MGG. 243(6). 660–665. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact